Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16983112 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: exatecan mesylate;   Drug: gemcitabine hydrochloride

Indicates status has not been verified in more than two years